Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Local anesthetics; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; Medicinal preparations of the treatment of infectious diseases and for use in oncology; Anesthetics; Anesthetics for surgical purposes; Pharmaceutical preparations for treating diabetes; Anti-diabetic pharmaceuticals; Cardiovascular agents for medical purposes; Drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; Skeletal muscle relaxants; Pharmaceutical preparations for treating hypertension; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Anesthetics for surgical and non-surgical use; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for use in chemotherapy; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Transdermal patches for use in the treatment of neurodegenerative disease; Cardiovascular pharmaceuticals; Hypolipidemic agents; Anesthetics for surgical use; Pain relief medication; Pharmaceutical products for the treatment of cancer; Hypolipidemic agents

Mark Details

Serial Number

No 90318022

Mark Type

No Service/Collective Mark

Attorney Docket Number

No MR3575-227

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

26.07.28 -

Miscellaneous designs with overall diamond shape, including letters forming or comprising a diamond

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History

Status Date	Action Taken
12^th Sep 2022	ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
12^th Sep 2022	ABANDONMENT - NO USE STATEMENT FILED
01^st Feb 2022	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28^th Jan 2022	SOU EXTENSION 1 GRANTED
28^th Jan 2022	SOU EXTENSION 1 FILED
28^th Jan 2022	TEAS EXTENSION RECEIVED
10^th Aug 2021	NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15^th Jun 2021	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15^th Jun 2021	PUBLISHED FOR OPPOSITION
26^th May 2021	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

OEP PHARMA

Classification Information

Class [005]Pharmaceutical Products